Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001452430-08-000001
Filing Date
2008-12-18
Accepted
2008-12-18 17:13:20
Documents
1
Period of Report
2008-12-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1408
  Complete submission text file 0001452430-08-000001.txt   3468
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 20 HAIFA L3 31905
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 20 HAIFA L3 31905 972-4-850-1080
PLURISTEM THERAPEUTICS INC (Issuer) CIK: 0001158780 (see all company filings)

EIN.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 4 BERKOWITZ STREET TEL-AVIV L3 64238
Business Address 972-3-6074040
Pines Shai (Reporting) CIK: 0001452430 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-31392 | Film No.: 081258005